Statistically significant differences were found between patients with RA-ILD+ and RA-ILD- regarding the following demographic and clinical features: age, C-reactive protein (CRP) levels, disease activity score 28-CRP, rheumatoid factor and anti-cyclic citrullinated peptide antibodies status (Table 1). This evidence concerns the gene CRP and rheumatoid arthritis.